Phase I and Pharmacologic Study of Infusional Topotecan and Carboplatin in Relapsed and Refractory Acute Leukemia-Reference-Cited by-同舟云学术

Phase I and Pharmacologic Study of Infusional Topotecan and Carboplatin in Relapsed and Refractory Acute Leukemia

Published:2005-09-15 Issue:18 Volume:11 Page:6641-6649
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Kaufmann Scott H.,Karp Judith E.,Letendre Louis,Kottke Timothy J.,Safgren Stephanie,Greer Jackie,Gojo Ivana,Atherton Pamela,Svingen Phyllis A.,Loegering David A.,Litzow Mark R.,Sloan Jeff A.,Reid Joel M.,Ames Matthew M.,Adjei Alex A.,Erlichman Charles

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders;Biochemical Pharmacology;2019-09

2. A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease;American Journal of Hematology;2018-11-15

3. A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors;Clinical Cancer Research;2017-11-14

4. Exposure–Response of Veliparib to Inform Phase II Trial Design in Refractory or Relapsed Patients with Hematological Malignancies;Clinical Cancer Research;2017-07-27

5. Population pharmacokinetics and site of action exposures of veliparib with topotecan plus carboplatin in patients with haematological malignancies;British Journal of Clinical Pharmacology;2017-03-19